Link – Page 2 – NovAccess Global

Innovest Global Provides August Shareholder Update with Milestones Including Patent Approval, Biotech Progress, Financial Achievements

StemVax Obtains the Exclusive Worldwide Rights to Four Key Technologies

Innovest Global Announces Patent is Approved for StemVax Therapeutics

Innovest Global Acquires Stake in StemVax Therapeutics| Innovest Global

Innovest Global Inc. Signs Letter of Intent to Acquire 20% of StemVax Therapeutics, a Biotechnology & Health Sciences Company

Innovest Global Inc. to Launch Biotech and Health Sciences Division Led by World Renowned Neuroscientist, Dr. Dwain Morris-Irvin

Revolutionary advances in the understanding of how our bodies can fight cancer, and how to put that information to use in treating existing tumors. NovAccess Global’s team of experts is working to strengthen the capability of the human body’s defense against cancer.

Forward-Looking Statements

Contact Us

JOIN US

Stay up-to-date with our journey

Privacy Policy

Privacy Policy

Forward-Looking Statements